# Cava Group, Inc.: overview

CAVA · NYSE · CIK 1639438 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/cava.md) · [Financials](/companies/cava/financials.md) · [Filings](/companies/cava/filings.md) · [Insiders](/companies/cava/insiders.md)

Latest reported revenue: [$368.4m](/filings/0001628280-26-055864.md) for Q2 FY2026, three months to 2026-07-12, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-055864).

## Last eight quarters

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q2 FY2024 (2024-07-14) | Q3 FY2024 (2024-10-06) | Q4 FY2024 (2024-12-29) | Q2 FY2025 (2025-07-13) | Q3 FY2025 (2025-10-05) | Q4 FY2025 (2025-12-28) | Q2 FY2026 (2026-07-12) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [177 d](/filings/0001628280-26-011296.md) | [233](/filings/0001639438-25-000007.md) | [244](/filings/0001628280-25-049080.md) | [227 d](/filings/0001628280-26-011296.md) | [281](/filings/0001628280-26-055864.md) | [292](/filings/0001628280-25-049080.md) | [275 d](/filings/0001628280-26-011296.md) | [368](/filings/0001628280-26-055864.md) |
| Gross margin | % | [22.5% d](/filings/0001628280-24-007277.md) | [26.7%](/filings/0001628280-24-038276.md) | [25.7%](/filings/0001628280-24-047336.md) | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(0.9%) d](/filings/0001628280-26-011296.md) | [6.9%](/filings/0001639438-25-000007.md) | [5.6%](/filings/0001628280-25-049080.md) | [1.7% d](/filings/0001628280-26-011296.md) | [7.0%](/filings/0001628280-26-055864.md) | [5.9%](/filings/0001628280-25-049080.md) | [1.0% d](/filings/0001628280-26-011296.md) | [7.3%](/filings/0001628280-26-055864.md) |
| Net margin | % | [1.2% d](/filings/0001628280-26-011296.md) | [8.5%](/filings/0001639438-25-000007.md) | [7.4%](/filings/0001628280-25-049080.md) | [34.6% d](/filings/0001628280-26-011296.md) | [6.5%](/filings/0001628280-26-055864.md) | [5.0%](/filings/0001628280-25-049080.md) | [1.8% d](/filings/0001628280-26-011296.md) | [6.2%](/filings/0001628280-26-055864.md) |
| Diluted EPS | $ per share | not reported | [0.17](/filings/0001639438-25-000007.md) | [0.15](/filings/0001628280-25-049080.md) | not reported | [0.16](/filings/0001628280-26-055864.md) | [0.12](/filings/0001628280-25-049080.md) | not reported | [0.19](/filings/0001628280-26-055864.md) |
| Free cash flow | $m | [(7.2) d](/filings/0001628280-26-011296.md) | not reported | [23.4 d](/filings/0001628280-25-049080.md) | [2.1 d](/filings/0001628280-26-011296.md) | not reported | [1.4 d](/filings/0001628280-25-049080.md) | [2.9 d](/filings/0001628280-26-011296.md) | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-26) | FY (2022-12-25) | FY2023 (2023-12-31) | FY2024 (2024-12-29) | FY2025 (2025-12-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [500](/filings/0001628280-24-007277.md) | [564](/filings/0001628280-25-007882.md) | [729](/filings/0001628280-26-011296.md) | [964](/filings/0001628280-26-011296.md) | [1,180](/filings/0001628280-26-011296.md) |
| Gross margin | % | [16.4%](/filings/0001628280-24-007277.md) | [17.4%](/filings/0001628280-24-007277.md) | [24.7%](/filings/0001628280-24-007277.md) | not reported | not reported |
| Operating margin | % | [(10.5%)](/filings/0001628280-24-007277.md) | [(10.6%)](/filings/0001628280-25-007882.md) | [0.6%](/filings/0001628280-26-011296.md) | [4.5%](/filings/0001628280-26-011296.md) | [4.7%](/filings/0001628280-26-011296.md) |
| Net margin | % | [(7.5%)](/filings/0001628280-24-007277.md) | [(10.5%)](/filings/0001628280-25-007882.md) | [1.8%](/filings/0001628280-26-011296.md) | [13.5%](/filings/0001628280-26-011296.md) | [5.4%](/filings/0001628280-26-011296.md) |
| Diluted EPS | $ per share | [(51.06)](/filings/0001628280-24-007277.md) | [(44.41)](/filings/0001628280-25-007882.md) | [0.21](/filings/0001628280-26-011296.md) | [1.10](/filings/0001628280-26-011296.md) | [0.54](/filings/0001628280-26-011296.md) |
| Free cash flow | $m | [(52.9)](/filings/0001628280-24-007277.md) | [(98.1)](/filings/0001628280-25-007882.md) | [(41.7)](/filings/0001628280-26-011296.md) | [52.9](/filings/0001628280-26-011296.md) | [26.1](/filings/0001628280-26-011296.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cava/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $757.0m | 9,645,932 |  | Added +77,945 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $537.4m | 6,642,936 |  | Reduced −2,543,018 |
| [Artal Group S.A.](/funds/1053906.md) | 2026-06-30 | $510.7m | 6,507,990 |  | Reduced −3,000,000 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $433.9m | 5,528,752 |  | Reduced −383,015 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $352.1m | 4,486,095 |  | Added +40,711 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $330.7m | 4,213,225 |  | Added +20,526 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $243.2m | 3,098,230 |  | Added +92,626 |
| [1832 Asset Management L.P.](/funds/944388.md) | 2026-06-30 | $198.2m | 2,525,500 |  | Added +1,006,300 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $166.9m | 2,127,156 |  | Added +276,546 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $161.5m | 2,058,240 |  | Reduced −551,807 |

## Recent filings

[All 401 filings](/companies/cava/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-18 | 07:04 ET | [8-K](/filings/0001628280-26-062616.md) | 8.01 Other events | 0001628280-26-062616 |
| 2026-08-12 | 18:08 ET | [10-Q](/filings/0001628280-26-055864.md) | Quarterly report, period 2026-07-12 | 0001628280-26-055864 |
| 2026-08-11 | 16:15 ET | [8-K](/filings/0001628280-26-055709.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055709 |
| 2026-08-03 | 09:17 ET | [8-K](/filings/0001628280-26-051556.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-051556 |
| 2026-06-24 | 09:24 ET | [8-K](/filings/0001628280-26-045042.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-045042 |
| 2026-05-20 | 18:07 ET | [10-Q](/filings/0001628280-26-036625.md) | Quarterly report, period 2026-04-19 | 0001628280-26-036625 |
| 2026-05-19 | 16:17 ET | [8-K](/filings/0001628280-26-036461.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-036461 |
| 2026-04-24 | 16:21 ET | [DEF 14A](/filings/0001628280-26-027224.md) | Proxy statement, period 2026-06-22 | 0001628280-26-027224 |
| 2026-04-21 | 16:15 ET | [8-K](/filings/0001628280-26-026283.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-026283 |
| 2026-03-25 | 13:54 ET | [8-K](/filings/0001628280-26-020983.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-020983 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 28, 2025](/filings/0001628280-26-011296.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1639438
- Tickers: CAVA
- Exchange: NYSE
- SIC code: 5812 Retail-Eating  Places
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.